358 , 580591 (2008) Griffin, S.J., Borch-Johnsen, K., Davies, M.J., Khunti, K., Rutten, G.E., Sandbk, A., Sharp, S.J., Simmons, R.K., van den Donk, M., Wareham, N.J., Lauritzen, T.: Effect of early intensive multifactorial therapy on 5-year cardiovascular outcomes in individuals with type 2 diabetes detected by screening (ADDITION-Europe): a cluster-randomised trial
But before, I felt like you couldnt even see my eyes because all you could see were my cheeks
Key highlights Both semaglutide and dulaglutide are GLP-1 medications with the same mechanism of action
When experiencing symptoms of dizziness or lightheadedness, patients should check their blood glucose to differentiate hypotension from hypoglycemia, as symptoms can overlap
SLC22A5 is regulated by peroxisome proliferator-activated receptor alpha